California Public Employees Retirement System lowered its stake in Orthofix International NV (NASDAQ:OFIX) by 6.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 86,600 shares of the medical device company’s stock after selling 5,800 shares during the period. California Public Employees Retirement System owned approximately 0.48% of Orthofix International NV worth $3,672,000 as of its most recent filing with the SEC.

A number of other institutional investors have also recently bought and sold shares of the company. UBS Asset Management Americas Inc. raised its position in Orthofix International NV by 1.2% in the first quarter. UBS Asset Management Americas Inc. now owns 9,111 shares of the medical device company’s stock valued at $378,000 after buying an additional 111 shares during the last quarter. Swiss National Bank raised its position in Orthofix International NV by 2.2% in the second quarter. Swiss National Bank now owns 32,900 shares of the medical device company’s stock valued at $1,395,000 after buying an additional 700 shares during the last quarter. Royal Bank of Canada raised its position in Orthofix International NV by 28.0% in the first quarter. Royal Bank of Canada now owns 12,913 shares of the medical device company’s stock valued at $536,000 after buying an additional 2,828 shares during the last quarter. DIAM Co. Ltd. raised its position in Orthofix International NV by 19.3% in the second quarter. DIAM Co. Ltd. now owns 26,065 shares of the medical device company’s stock valued at $1,105,000 after buying an additional 4,214 shares during the last quarter. Finally, TIAA CREF Investment Management LLC raised its position in Orthofix International NV by 4.7% in the first quarter. TIAA CREF Investment Management LLC now owns 95,843 shares of the medical device company’s stock valued at $3,979,000 after buying an additional 4,269 shares during the last quarter. 91.26% of the stock is currently owned by hedge funds and other institutional investors.

Orthofix International NV (NASDAQ:OFIX) traded down 0.93% during midday trading on Friday, reaching $43.56. The company’s stock had a trading volume of 91,055 shares. The company’s market capitalization is $789.48 million. Orthofix International NV has a 1-year low of $32.25 and a 1-year high of $48.25. The company has a 50 day moving average of $43.88 and a 200-day moving average of $43.71.

Orthofix International NV (NASDAQ:OFIX) last released its quarterly earnings results on Monday, August 1st. The medical device company reported $0.41 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.08. Orthofix International NV had a positive return on equity of 8.50% and a negative net margin of 0.37%. The company earned $104.10 million during the quarter, compared to analysts’ expectations of $102.40 million. During the same period in the previous year, the firm posted $0.36 earnings per share. The business’s revenue for the quarter was up 3.1% compared to the same quarter last year. Equities research analysts anticipate that Orthofix International NV will post $1.41 earnings per share for the current fiscal year.

Several research firms recently issued reports on OFIX. TheStreet lowered Orthofix International NV from a “buy” rating to a “hold” rating in a research note on Wednesday, August 3rd. Zacks Investment Research raised Orthofix International NV from a “hold” rating to a “strong-buy” rating and set a $49.00 target price on the stock in a research note on Thursday, August 4th.

In other news, insider Michael Finegan sold 25,000 shares of the business’s stock in a transaction on Thursday, September 1st. The stock was sold at an average price of $45.16, for a total value of $1,129,000.00. Following the completion of the transaction, the insider now directly owns 51,670 shares of the company’s stock, valued at $2,333,417.20. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 5.10% of the stock is owned by insiders.

About Orthofix International NV

Orthofix International N.V. (Orthofix) is a global medical device company. The Company is focused on providing reconstructive and regenerative orthopedic and spine solutions to physicians. The company operates in four segments: BioStim, Biologics, Extremity Fixation and Spine Fixation. Its BioStim solutions products include Cervical-Stim, Spinal-Stim and Physio-Stim.

5 Day Chart for NASDAQ:OFIX

Want to see what other hedge funds are holding OFIX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Orthofix International NV (NASDAQ:OFIX).

Receive News & Ratings for Orthofix International NV Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orthofix International NV and related companies with MarketBeat.com's FREE daily email newsletter.